We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

A Sweat-Based On-Site Immunoassay for Monitoring Marijuana Use

By LabMedica International staff writers
Posted on 16 Jan 2020
Print article
Image: A dried flower bud of the Cannabis plant. The cannabis' flowers contain many different psychoactive compounds that are used for recreational or medicinal purposes (Photo courtesy of Wikimedia Commons)
Image: A dried flower bud of the Cannabis plant. The cannabis' flowers contain many different psychoactive compounds that are used for recreational or medicinal purposes (Photo courtesy of Wikimedia Commons)
A novel sweat-based skin test enables on-site testing for tetrahydrocannabinol (THC), the main psychoactive component found in marijuana plants (Cannabis).

This development was made in response to the increase in the number of states legalizing marijuana. This has left law enforcement in a situation where the use and consumption of the drug are legal, but there are no limitations for what is acceptable for driving or operating machinery. The prototype THC detector anticipates the formulation of laws restricting THC consumption by drivers and the need for the police to be able to detect abuse of the substance.

Investigators at University at Albany, State University of New York (USA) had already developed a sweat-based device for measurement of alcohol in the blood. The new device operates in a similar fashion but displays a color change when THC interacts with a specific antibody.

In the new assay system, the THC metabolite and an enzyme-labeled conjugate compete against each other as the antigens for the system. The antibody used in this assay has a greater affinity for the metabolite; so as its concentration increases, the absorbance of the system decreases due to reduced binding of the enzyme-labeled conjugate. Thus, the presence of THC in the sample inhibits the color change generated by the test, and the greater the amount of THC metabolite present in the sweat sample, the less color is produced by the test reagents.

“Currently there is a zero-tolerance policy when it comes to marijuana use and operating machinery,” said senior author Dr Jan Halámek, assistant professor of chemistry at the University at Albany. “While many states are moving to various stages of legalization, the focus is mostly on possession and in-home use. There are no reliable roadside devices being used to test for marijuana-impaired driving. What makes the use of sweat as a biometric unique is that it is non-invasive. No blood needs to be drawn for a sample. Our test can be done instantaneously, on the side of the road, which eliminates any possibility of tampering.”

“While drugs are a new topic for the Halámek lab, it is something we plan to continue diving into,” said Dr. Halámek. “Much of the fundamentals are the same as our previous research in terms of the collection, extraction, and use of sweat as a biometric.”

The THC sweat-based assay was described in the December 3, 2019, online edition of the journal ACS Sensors.

Related Links:
University at Albany, State University of New York

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more